Pennsylvania 2025-2026

SB 866

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.

Open original source Back to bills

Official record

Measure details

Jurisdiction: Pennsylvania
Session: 2025-2026
Chamber: upper
Classification: bill
Subjects: Not supplied
Introduced / first action: 2025-07-24 04:00:00

Actions

2026-06-10 04:00:00
Referred to Judiciary
referral-committee
2026-06-09 04:00:00
Third consideration and final passage
passage, reading-3
2026-06-08 04:00:00
Re-reported as committed
committee-passage
2026-06-03 04:00:00
Re-referred to Appropriations
referral-committee
2026-06-03 04:00:00
Second consideration
reading-2
2026-06-02 04:00:00
First consideration
reading-1
2026-06-02 04:00:00
Reported as committed
committee-passage
2025-07-24 04:00:00
Referred to Agriculture & Rural Affairs
referral-committee

Documents and versions

Official links

Recorded votes

Roll calls

When supplied by the API

Related measures

No resolvable related measure is supplied.

Traceable provenance

Source records

Provider updated: 2026-07-29 02:55:02. Locally fetched: 2026-07-29 14:13:33.